News
Pharma Update | Fingolimod Preliminary Injunction also rejected in Appeal
In its interim relief decision of 18 October 2022, the Court of Appeal of The Hague affirms the first instance decision in which the PI judge of the District Court rejected Novartis’ claim for a preliminary injunction against Mylan. The Court of Appeal also held Novartis’ EP 2 959 894 (“EP 894”) re fingolimod 0,5
Read more ›
BarentsKrans advises TAQA on sale of Upstream business to Waldorf
TAQA Energy B.V. (TAQA) has announced that it has sold its Upstream oil & gas activities in the Netherlands to Waldorf Energy Netherlands B.V. (Waldorf). BarentsKrans has advised TAQA on the employment related aspects of the split between TAQA’s Upstream activities and its other activities, for example its gas storage facility in the Alkmaar area,
Read more ›
BarentsKrans assisted the Swedish ARC on entry into the Benelux
The Swedish ARC, a multi-brand consultancy agency, has acquired Dutch design agency Fabrique and digital agency Q42. BarentsKrans assisted ARC with both acquisitions, which mark ARC’s first steps in the Benelux. Swedish ARC combines multi-brand consultancy expertise in communications, innovation, branding, design, tech and marketing and has grown rapidly in the Nordics to a 1.000+
Read more ›
ESG: what is it and is it becoming ever more important?
ESG stands for Environment, Society and Governance. The assessment of a company’s sustainability is based on the impact that company has on the environment (waste, pollution, etc.), the impact on society (working conditions, health and safety, etc.) and how a company is managed (e.g., executive remuneration, diversity and signs of corruption or bribery, etc.).[1] Investors
Read more ›
Pharma update | PI judge holds fingolimod 0.5 mg patent provisionally invalid
In its interim relief decision of 21 June 2022 the PI Judge of the District Court of The Hague held Novartis’ EP 2 959 894 (“EP 894”) re fingolimod 0.5 mg provisionally invalid. This is the first substantive PI decision on this matter in Europa, where several proceedings between Novartis and Mylan are pending. In
Read more ›
BarentsKrans advises Van de Velde Packaging on the acquisition of Dozenhal
BarentsKrans has advised Van de Velde Packaging on the acquisition of Dozenhal. Dozenhal has two warehouses and a production facility in the Netherlands and a sales team in Germany. The company claims to have “the largest stock of cardboard boxes in the Netherlands”. “Corrugated cardboard boxes are produced in small quantities at the production location
Read more ›
Pharma update | Apixaban patent and SPC provisionally held invalid
In its decision of 10 May 2022 in PI proceedings between Bristol-Myers Squibb Holdings Ireland Unlimited Company (“BMS”) and Sandoz B.V. (“Sandoz”), the PI judge of the District Court of The Hague denied BMS’ claim for injunctive relief regarding the sale of generic apixaban by Sandoz. According to the Judge, there is no inventive step
Read more ›
Court finds Mammoet’s press release unlawful
Huisman had issues a press announcement that it had concluded an agreement with BMW for the design and construction of a so-called “ringer crane”, a special kind of heavy-lifting land cranes. Following Huisman’s press statement, Mammoet issued a press release entitled “Mammoet starts investigation of patent infringement by Huisman and BMS”, in which it refers
Read more ›
BarentsKrans repels Novartis’ bid for fingolimod PI
The District Court of The Hague (Provisions Judge) has rejected Novartis’ application, based on a patent application, for a preliminary injunction (PI), meaning Mylan can market its generic drug containing fingolimod in the Netherlands at least prior to the grant of the patent. The EPO’s Technical Board of Appeal had recently cleared the way for
Read more ›
Legal 500 EMEA 2022: “Partner involvement, all areas in-house, professional juniors”
This week the Legal 500 published its’ 2022 edition. We are honoured to again have received excellent rankings this year. BarentsKrans has been ranked as Top Tier Firm in Employment Law and has been recommended in no less than ten practice areas. A special mention goes to Joost Fanoy who was listed as Leading Individual
Read more ›
